Siemens Healthineers AG/ADR (SEMHF)
Siemens Healthineers AG, along with its affiliated companies, offers a global portfolio of diagnostic and therapeutic solutions, which it designs, produces, and markets to healthcare organizations worldwide. The company's operations are structured into four distinct divisions: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging division specializes in advanced medical imaging technologies, encompassing magnetic resonance imaging (MRI), computed tomography (CT), X-ray equipment, molecular imaging techniques, and ultrasound systems. Within the Diagnostics division, the focus is on supplying in-vitro diagnostic solutions and services to healthcare professionals across various settings, including laboratory, molecular, and point-of-care environments. It also delivers laboratory workflow optimization tools and informatics solutions. The Varian segment is dedicated to oncology, furnishing cancer care technologies, comprehensive solutions, and support services to hospital and clinic oncology departments. This includes advanced workflow optimization through technology, expert clinical services and consultancy, as well as digital tools and applications designed to streamline and oversee patient treatment and therapy protocols. The Advanced Therapies division delivers products engineered to facilitate image-guided, minimally invasive procedures in fields such as cardiology, interventional radiology, and surgery. Its offerings extend to angiography systems and mobile C-arms, notably featuring a robotic-assisted platform for endovascular interventions involving coronary and peripheral vasculature. Beyond these core segments, Siemens Healthineers also offers a suite of supplementary services. These comprise managing equipment performance, clinical training and e-learning programs, asset management, and outsourced departmental services for both laboratories and wider healthcare institutions, alongside consulting and digital health solutions. Headquartered in Erlangen, Germany, Siemens Healthineers AG functions as a subsidiary of Siemens Aktiengesellschaft.
Industry: Medical - Devices
Siemens Healthineers AG
+1.12%$50.41
Prev close$49.85+1.12%Close$50.41
Mkt Cap$56.42B
Float267.17M
O/S1.12B
Inst Own-
SI1.3%
Div Yield2.36%
Dilution
Financials Summary
Revenue$26.38B
Net Income$2.47B
Total Assets$52.15B
Free Cash Flow$2.73B
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$22.16B
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in SEMHF's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$52.15B
Liabilities$29.91B
Accounts Receivable$8.1B
Accounts Payable$2.85B
Inventory$5.05B
PP&E (Net)$5.71B
Goodwill$19.51B
Intangible Assets$7.22B
Income Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-09-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 |
| Revenue | $26.38B | $26.15B | $24.97B | $24.21B | $24.24B | $20.09B | $16.14B | $16.21B | $14.99B | $15.27B | $15.13B | $14.44B |
| YoY Growth | 0.9% | 4.7% | 3.2% | -0.2% | 20.7% | 24.5% | -0.4% | 8.1% | -1.8% | 1.0% | 4.7% | - |
| Cost of Revenue | $16.21B | $16.05B | $15.51B | $15.6B | $15.16B | $12.33B | $9.91B | $9.74B | $8.89B | $8.91B | $9.02B | $8.78B |
| Gross Profit | $10.18B | $10.1B | $9.45B | $8.61B | $9.08B | $7.76B | $6.23B | $6.47B | $6.11B | $6.36B | $6.1B | $5.66B |
| Gross Margin | 38.6% | 38.6% | 37.9% | 35.6% | 37.5% | 38.6% | 38.6% | 39.9% | 40.7% | 41.6% | 40.4% | 39.2% |
| Research and Development | $2.2B | $2.19B | $2.14B | $2.08B | $1.99B | $1.73B | $1.5B | $1.48B | $1.43B | $1.4B | $1.28B | $1.18B |
| Selling, General, and Administrative | $4.44B | $4.07B | $3.63B | $3.8B | $3.67B | $2.94B | $2.45B | $2.41B | $2.4B | $2.48B | $2.46B | $2.35B |
| Other | -$24.56M | -$1.12M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $6.61B | $6.26B | $5.77B | $5.88B | $5.66B | $4.66B | $3.95B | $3.89B | $3.83B | $3.88B | $3.74B | $3.53B |
| Operating Income (EBIT) | $3.57B | $3.84B | $3.68B | $2.72B | $3.42B | $3.1B | $2.28B | $2.58B | $2.27B | $2.48B | $2.36B | $2.13B |
| Operating Margin | 13.5% | 14.7% | 14.8% | 11.3% | 14.1% | 15.4% | 14.1% | 15.9% | 15.1% | 16.2% | 15.6% | 14.7% |
| Interest Expense | $455.53M | $475.4M | $531.45M | $330.48M | $131.75M | $92.67M | $84.85M | $137.33M | $228.88M | $298.11M | $241.16M | $130.63M |
| Interest Income | $127.28M | $110.74M | $132.86M | $94.9M | $53.59M | $36.84M | $59.17M | $42.43M | $45.78M | $13.4M | $15.63M | $21.21M |
| Other Income (Expense) | -$339.42M | -$650.92M | -$867.52M | -$571.65M | -$294.76M | -$416.45M | -$96.02M | -$132.86M | -$262.38M | -$271.31M | -$221.07M | -$32.38M |
| Income Before Tax (EBT) | $3.23B | $3.19B | $2.82B | $2.15B | $3.13B | $2.68B | $2.18B | $2.45B | $2.01B | $2.21B | $2.14B | $2.09B |
| Income Tax Expense | $721.26M | $766.23M | $629.71M | $449.95M | $832.91M | $734.66M | $592.86M | $677.72M | $575M | $648.69M | $658.74M | $652.04M |
| Net Income | $2.47B | $2.4B | $2.17B | $1.68B | $2.28B | $1.93B | $1.58B | $1.75B | $1.41B | $1.54B | $1.46B | $1.43B |
| Net Income Margin | 9.4% | 9.2% | 8.7% | 7.0% | 9.4% | 9.6% | 9.8% | 10.8% | 9.4% | 10.1% | 9.7% | 9.9% |
| Supplementary Data | ||||||||||||
| EPS | 1.98 | 1.92 | 1.74 | 1.35 | 1.82 | 1.57 | 1.41 | 1.57 | 1.27 | 1.38 | 1.31 | 1.28 |
| Diluted EPS | 1.97 | 1.91 | 1.73 | 1.34 | 1.81 | 1.56 | 1.41 | 1.57 | 1.26 | 1.38 | 1.31 | 1.28 |
| Weighted Average OS | 1.12B | 1.12B | 1.12B | 1.12B | 1.12B | 1.10B | 1.00B | 999.25M | 999.90M | 1.00B | 1.00B | 1.00B |
| EBITDA | $5.01B | $5.13B | $4.72B | $4.22B | $4.76B | $3.93B | $3.17B | $3.27B | $2.82B | $3.13B | $3.04B | $2.84B |
| EBITDA Margin | 19.0% | 19.6% | 18.9% | 17.4% | 19.6% | 19.6% | 19.7% | 20.2% | 18.8% | 20.5% | 20.1% | 19.7% |
Balance Sheet
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-09-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 |
| Assets | ||||||||||||
| Current Assets | ||||||||||||
| Cash and Cash Equivalents | $2.84B | $2.43B | $3B | $1.83B | $1.6B | $1.48B | $732.42M | $1.03B | $579.46M | $205.44M | $230M | $81.5M |
| Short-Term Investments | $461.11M | $81.5M | $0 | $0 | $0 | $0 | $0 | $0 | $30.15M | $12.28M | $18.98M | $41.31M |
| Cash and Short-Term Investments | $3.3B | $2.51B | $3B | $1.83B | $1.6B | $1.48B | $732.42M | $1.03B | $609.61M | $217.72M | $248.98M | $122.81M |
| Accounts Receivable | $8.1B | $7.3B | $8.04B | $8.36B | $7.89B | $6.71B | $7.9B | $5.22B | $5.3B | $6.6B | $7.07B | $6.85B |
| Inventory | $5.05B | $4.56B | $4.67B | $4.79B | $4.48B | $3.55B | $2.57B | $2.3B | $2.04B | $1.79B | $1.46B | $1.41B |
| Other Current Assets | $1.03B | $3.84B | $218.83M | $569.41M | $762.57M | $148.49M | $158.54M | $70.34M | $37.96M | $37.96M | $11.16M | $12.28M |
| Total Current Assets | $17.47B | $18.47B | $16.13B | $15.78B | $14.94B | $12.04B | $11.46B | $8.69B | $8.04B | $8.7B | $8.84B | $8.43B |
| Long-Term Assets | ||||||||||||
| Property, Plant & Equipment Net | $5.71B | $5.26B | $5B | $4.7B | $4.77B | $4.14B | $3.1B | $2.59B | $2.14B | $1.75B | $1.7B | $1.46B |
| Goodwill | $19.51B | $19.12B | $19.72B | $20.23B | $21.28B | $19.49B | $10.09B | $9.59B | $9.13B | $8.92B | $9.27B | $9.24B |
| Intangible Assets | $7.22B | $7.26B | $7.88B | $8.63B | $9.73B | $9.01B | $2.13B | $1.76B | $1.75B | $1.7B | $1.77B | $1.79B |
| Long-Term Investments | $0 | $1.28B | $1.57B | $1.78B | $2.91B | $1.07B | $434.32M | $427.62M | $235.58M | $1.74B | $208.79M | $205.44M |
| Deferred Tax Assets | $509.12M | $537.16M | $531.45M | $464.46M | $641.99M | $537.04M | $467.81M | $515.82M | $439.9M | $455.53M | $585.05M | $333.83M |
| Other Long-Term Assets | $1.72B | $6.73B | $592.86M | $535.92M | $497.96M | $513.59M | $328.25M | $358.4M | $321.55M | $299.22M | $281.36M | $272.43M |
| Total Long-Term Assets | $34.67B | $39.66B | $35.29B | $36.34B | $39.83B | $34.77B | $16.55B | $15.24B | $14.02B | $14.87B | $13.81B | $13.29B |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $52.15B | $58.13B | $51.42B | $52.12B | $54.77B | $46.81B | $28.02B | $23.93B | $22.06B | $23.57B | $22.66B | $21.72B |
| Liabilities | ||||||||||||
| Current Liabilities | ||||||||||||
| Accounts Payable | $2.85B | $3.01B | $2.37B | $2.46B | $2.58B | $2.14B | $1.51B | $1.57B | $1.43B | $1.25B | $1.11B | $1.05B |
| Short-Term Debt | $0 | $4.16B | $3.07B | $4.91B | $3.17B | $2.4B | $2.46B | $490.14M | $769.27M | $6.51B | $4.59B | $9.48B |
| Current Income Tax Payable | $589.51M | $1.23B | $436.55M | $947.91M | $1.07B | $844.07M | $640.87M | $600.68M | $458.88M | $136.21M | $125.05M | $152.96M |
| Current Unearned Revenue | $0 | $4.77B | $4.05B | $4.05B | $4.19B | $3.24B | $1.99B | $1.94B | $1.7B | $1.57B | $615.19M | $592.86M |
| Other Current Liabilities | $8.04B | $8.32B | $1.38B | $1.47B | $1.37B | $1.29B | $787.13M | $869.75M | $816.16M | $817.28M | $3.01B | $3.09B |
| Total Current Liabilities | $14.76B | $16.57B | $12.92B | $15.01B | $13.42B | $11.29B | $8.14B | $6.26B | $5.92B | $11.29B | $10.39B | $15.23B |
| Long-Term Liabilities | ||||||||||||
| Long-Term Debt | $0 | $14.2B | $14.43B | $13.18B | $14.9B | $13.05B | $3.32B | $4.54B | $4.47B | $5.77B | $6.12B | $14.51M |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $253.45M | $254.56M | $253.45M | $492.38M | $420.92M |
| Long-Term Deferred Tax Liabilities | $1.2B | $1.51B | $1.69B | $1.86B | $2.36B | $2.32B | $524.75M | $418.69M | $388.54M | $289.17M | $219.95M | $177.52M |
| Other Long-Term Liabilities | $13.95B | $1.5B | $1.42B | $1.33B | $1.41B | $1.69B | $1.71B | $1.51B | $1.32B | $2.28B | $2.73B | $1.7B |
| Total Long-Term Liabilities | $15.15B | $17.86B | $18.13B | $16.87B | $19.18B | $17.59B | $5.91B | $6.75B | $6.45B | $8.61B | $9.58B | $2.33B |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $29.91B | $34.43B | $31.05B | $31.88B | $32.61B | $28.89B | $14.05B | $13B | $12.37B | $19.9B | $19.97B | $17.56B |
| Stockholders' Equity | ||||||||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Common Stock | $1.26B | $1.48B | $1.26B | $1.26B | $1.26B | $1.26B | $1.2B | $1.12B | $1.12B | $0 | $3.51B | $4.9B |
| Retained Earnings | $4.88B | $4.24B | $2.4B | $1.54B | $998.15M | -$334.95M | -$1.42B | -$2.08B | -$3.37B | $4.52B | $0 | $0 |
| Comprehensive Income & Other | $0 | -$2.2B | -$582.81M | $379.61M | $2.63B | -$411.99M | -$827.33M | -$166.36M | $11.93B | -$853.01M | -$856.36M | -$777.08M |
| Other Stockholders' Equity | $16.02B | $17.91B | $16.65B | $17.39B | $19.89B | $16.98B | $14.18B | $11.87B | $11.92B | -$853.01M | -$856.36M | -$777.08M |
| Total Equity | $22.16B | $23.64B | $20.32B | $20.19B | $22.15B | $17.91B | $13.95B | $10.91B | $9.66B | $3.66B | $2.65B | $4.12B |
| Minority Interest | $75.92M | $66.82M | $54.71M | $58.06M | $17.86M | $20.1M | $14.51M | $14.51M | $22.33M | $8.93M | $36.84M | $43.54M |
| Total Liabilities and Equity | $52.07B | $58.06B | $51.37B | $52.06B | $54.75B | $46.79B | $28B | $23.91B | $22.04B | $23.56B | $22.62B | $21.68B |
| Supplementary Data | ||||||||||||
| Total Debt | $0 | $844.07M | $18.1B | $18.59B | $18.59B | $15.98B | $6.14B | $5.06B | $5.26B | $12.3B | $10.73B | $9.51B |
| Net Debt | -$2.84B | -$1.58B | $15.1B | $16.76B | $16.99B | $14.51B | $5.41B | $4.03B | $4.68B | $12.09B | $10.5B | $9.43B |
Cash Flow Statement
| Period | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2026-09-30 | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 | 2019-09-30 | 2018-09-30 | 2017-09-30 | 2016-09-30 | 2015-09-30 |
| Operating Activities | ||||||||||||
| Net Income | $2.5B | $2.4B | $2.17B | $1.68B | $2.27B | $1.93B | $1.58B | $1.75B | $1.41B | $1.54B | $1.46B | $1.43B |
| Depreciation & Amortization | $1.33B | $1.45B | $1.37B | $1.74B | $1.5B | $1.16B | $909.95M | $692.23M | $591.75M | $638.64M | $659.85M | $628.59M |
| Deferred Income Tax | $0 | -$337.18M | -$227.77M | -$295.87M | -$296.99M | -$97.14M | $43.54M | $7.82M | $55.83M | $15.63M | $0 | $0 |
| Stock-Based Compensation | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Changes in Working Capital: | ||||||||||||
| Accounts Receivable | -$602.91M | -$458.88M | -$471.16M | -$863.05M | -$545.97M | -$801.65M | $59.17M | -$541.5M | -$327.13M | -$189.81M | $0 | $0 |
| Inventory | -$248.98M | -$84.85M | $43.54M | -$505.77M | -$537.04M | -$24.56M | -$370.68M | -$138.45M | -$216.6M | -$96.02M | $0 | $0 |
| Accounts Payable | $0 | $256.16M | -$69.22M | -$22.33M | $275.78M | $355.05M | $1.12M | $100.48M | $187.57M | $186.46M | $0 | $0 |
| Other Working Capital | $698.93M | -$362.86M | -$178.64M | $451.07M | -$448.83M | $530.34M | -$235.58M | -$342.77M | -$403.06M | -$246.75M | -$212.13M | -$120.58M |
| Total Working Capital Change | -$152.96M | -$649.8M | -$675.48M | -$940.09M | -$1.26B | $59.17M | -$545.97M | -$922.23M | -$759.22M | -$346.12M | -$212.13M | -$120.58M |
| Other Non-Cash Items | -$6.7M | $588.4M | $126.16M | -$167.47M | $298.11M | $55.83M | $32.38M | $145.15M | $307.04M | $78.16M | -$46.89M | $92.67M |
| Net Cash from Operating | $3.67B | $3.45B | $2.76B | $2.02B | $2.52B | $3.11B | $2.02B | $1.67B | $1.61B | $1.93B | $1.86B | $2.03B |
| Investing Activities | ||||||||||||
| Capital Expenditures | -$940.09M | -$915.53M | -$777.08M | -$935.63M | -$951.26M | -$752.52M | -$621.89M | -$646.45M | -$591.75M | -$520.29M | -$473.4M | -$397.47M |
| Acquisitions | -$49.13M | -$96.02M | $37.96M | -$250.1M | -$15.63M | -$15.02B | -$1.51B | -$85.97M | -$235.58M | $14.51M | -$8.93M | $411.99M |
| Purchases of Investments | -$8.93M | -$2.23M | -$4.47M | -$7.82M | -$2.23M | -$13.4M | -$6.7M | -$6.7M | -$2.23M | $0 | -$4.47M | -$2.23M |
| Sales of Investments | $21.21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | -$976.94M | -$1.01B | -$743.59M | -$1.19B | -$969.12M | -$15.79B | -$2.13B | -$739.12M | -$829.56M | -$505.77M | -$486.79M | $12.28M |
| Financing Activities | ||||||||||||
| Debt Repaid | $193.15M | $147.38M | $241.16M | $212.13M | $166.36M | $154.08M | - | - | - | - | - | - |
| Common Stock Issuance | $0 | $0 | $0 | $20.1M | $1.12M | $2.58B | $3.02B | $0 | $0 | $0 | $0 | $0 |
| Common Stock Repurchases | -$179.76M | -$337.18M | -$11.16M | -$470.05M | -$345M | -$284.71M | -$74.81M | -$58.06M | -$62.52M | $0 | $0 | $0 |
| Dividends Paid | -$1.25B | -$1.19B | -$1.19B | -$1.19B | -$1.07B | -$955.72M | -$890.97M | -$780.43M | -$256.8M | -$393.01M | -$420.92M | -$165.24M |
| Other Financing Activities | -$489.03M | -$27.91M | -$17.86M | -$16.75M | -$21.21M | $12.22B | -$17.86M | -$16.75M | -$10.05M | -$3.35M | -$831.79M | -$1.8B |
| Net Cash from Financing | -$2.35B | -$2.9B | -$1.45B | -$424.27M | -$1.56B | $13.39B | -$140.68M | -$523.64M | -$372.91M | -$1.43B | -$1.23B | -$1.97B |
| Forex Effect | $62.52M | $46.15M | $600.68M | -$171.94M | $136.21M | $37.96M | -$34.61M | $37.96M | -$31.26M | -$13.4M | -$1.12M | $15.63M |
| Net Change in Cash | $409.76M | -$414.22M | $1.16B | $230M | $127.28M | $743.59M | -$294.76M | $447.72M | $374.03M | -$24.56M | $148.49M | $81.5M |
| Supplementary Data | ||||||||||||
| Operating Cash Flow | $3.67B | $3.45B | $2.76B | $2.02B | $2.52B | $3.11B | $2.02B | $1.67B | $1.61B | $1.93B | $1.86B | $2.03B |
| Capital Expenditure | -$940.09M | -$915.53M | -$777.08M | -$935.63M | -$951.26M | -$752.52M | -$621.89M | -$646.45M | -$591.75M | -$520.29M | -$473.4M | -$397.47M |
| Free Cash Flow | $2.73B | $2.53B | $1.98B | $1.08B | $1.57B | $2.35B | $1.39B | $1.03B | $1.02B | $1.41B | $1.39B | $1.63B |
| Cash at Beginning | $2.43B | $2.85B | $1.83B | $1.6B | $1.48B | $732.42M | $1.03B | $579.46M | $205.44M | $230M | $81.5M | $21.21M |
| Cash at End | $2.84B | $2.43B | $3B | $1.83B | $1.6B | $1.48B | $732.42M | $1.03B | $579.46M | $205.44M | $230M | $81.5M |